• Rhodie Smith to Present During 340B Health Webinar

    RxSrategies’ Rhodie Smith, Vice President – Contract Pharmacy Sales, will present during the 340B Health webinar, “340B Updates from the Field: Series 4” on August 26. Insight will be provided, including:   Tactics to successfully administer a conservative contract pharmacy program and implement an internal audit process Discuss best practices to help guide covered entities… Read more »

  • Stay on Top of 340B this Summer

    We are looking forward to connecting with you during the 340B Coalition Summer Conference being held July 15-17 in Washington, D.C. RxStrategies is proud to be a Pinnacle Sponsor for the event. Our team will be connecting with key leaders to discuss 340B comprehensive solutions, and share ideas on how to keep your 340B program on the right… Read more »

  • Achieve more with advanced analytics

    Did you know? Mixed-use inventory virtualization and replenishment platforms through RxStrategies are secure, user-friendly, highly customizable and work with all wholesalers and EHRs. In fact, RxStrategies’ integration of the Medi-Span drug database minimizes the need for manual NDC and multiplier mapping, while system-logic seamlessly complies with state-level MCO reporting requirements.   Real-time drug cost analytics… Read more »

  • Simplify 340B with Dashboard Analytics

    Our powerful analytics platform provides users with robust and insightful visibility into their 340B program. With an intuitive, cloud-based platform, an advanced reporting machine, and reliable analytics, RxStrategies’ Dashboard Analytics solution simplifies your entire 340B program. Real-time accumulator views, WAC-spend analyses, robust drill-down capabilities, and custom report creations provide our users access to the exact… Read more »

  • The Future of Policy at NACHC 2019

      March 27 – 30, RxStrategies representatives Rhodie Smith and Justin Rolling will attend the 2019 Policy and Issues Forum hosted by the National Association of Community Health Centers (NACHC). As one of the largest conferences on health policy, people from all corners of the administration and operations of health care will attend. The priorities… Read more »

  • 340B Insider – December 2018

    Welcome to the December edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. Visit our website to read more.   340B INDUSTRY NEWS Read below for recent news from 340B Health. THE U.S. HOUSE PASSES BILL TO KEEP DRUG COMPANIES FROM OVERCHARGING MEDICAID The bipartisan bill, from… Read more »

  • Clinical Insights: November 7, 2018

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Lorbrena® (lorlatinib) – New Drug Approval – November 2, 2018 – The Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with… Read more »

  • Clinical Insights: October 10, 2018

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval TegsediTM (inotersen) – October 5, 2018 – Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc., announced that the U.S. Food and Drug… Read more »

  • Clinical Insights: August 30, 2018

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval AltrenoTM (tretinoin) – August 24, 2018 – Ortho Dermatologics, one of the largest prescription dermatology healthcare businesses in the world, announced that the U.S. Food and Drug… Read more »